Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT01007942

Public ClinicalTrials.gov record NCT01007942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase III, Double-blind, Placebo-controlled Multicenter Trial of Daily Everolimus in Combination With Trastuzumab and Vinorelbine, in Pretreated Women With HER2/Neu Over-expressing Locally Advanced or Metastatic Breast Cancer.

Study identification

NCT ID
NCT01007942
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
569 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • everolimus Drug
  • trastuzumab Drug
  • vinorelbine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009
Primary completion
May 31, 2015
Completion
May 31, 2015
Last update posted
Apr 4, 2017

2009 – 2015

United States locations

U.S. sites
43
U.S. states
24
U.S. cities
33
Facility City State ZIP Site status
University of Arizona / Cancer Center AZ Onc Assoc Tucson Arizona 85724
University of Arizona / Cancer Center Deptof Uof A/Arizona Cancer(3) Tucson Arizona 85724
University of California San Diego - Moores Cancer Center La Jolla - UCSD Moores Cancer La Jolla California 92093-0658
Rocky Mountain Cancer Centers RMCC Greenwood Village Colorado
Georgetown University/Lombardi Cancer Center Dept.of Lombardi CancerCtr (3) Washington D.C. District of Columbia 20007-2197
Comprehensive Cancer Center - Boca Raton Deerfield Beach Boca Raton Florida 33248
Comprehensive Cancer Center - Boca Raton Dept.of BocaRatonCompCanCtr Boca Raton Florida 33248
Florida Cancer Specialists DeptofFloridaCancerSpecialists Fort Myers Florida 33916
Memorial Hospital Memorial Cancer Institute Hollywood Florida 33021
MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) Orlando Florida 32806
Emory University School of Medicine/Winship Cancer Institute Dept.of WinshipCancerInst. (2) Atlanta Georgia 30322
North Shore University Health System NSU Evanston Illinois 60201
Kansas City Cancer Center KCCC- South (2) Overland Park Kansas 66210
Maryland Oncology Hematology Owning Mills Maryland 21117,
Park Nicollet Institute Dept. of Park Nicollet Saint Louis Park Minnesota 55416
St. Louis University Cancer Center SLU Cancer Center St Louis Missouri 63110
University of Nebraska Medical Center Unv Nebraska Med Ctr (2) Omaha Nebraska 68198
Comprehensive Cancer Centers of Nevada CCC of Nevada Henderson (4) Las Vegas Nevada 89109
Nevada Cancer Institute Dept. of Nevada Cancer (3) Las Vegas Nevada 89135
Overlook Hospital - Carol G Simon Cancer Center Carol G Simon Summit New Jersey 07901
Clinical Research Alliance Dept.ofArenaOncologyAssoc(2) Lake Success New York 11042
Duke University Medical Center Dept. of DUMC (2) Durham North Carolina 27710
Northwest Cancer Specialists Tutlatin Portland Oregon 97210
University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) Pittsburgh Pennsylvania 15232
The Jones Clinic Dept .of The Jones Clinic (3) Germantown Tennessee 38138
Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(6) Nashville Tennessee 37203
Texas Cancer Center ( Medical City Dallas Hospital) Dept. of Texas Cancer Ctr. (2) Dallas Texas 75230
Texas Oncology Presbyterian Hospital (2) Dallas Texas 75246
Texas Oncology Texas Onc - Amarillo Dallas Texas 75246
Texas Oncology Texas Oncology - Sammons Dallas Texas 75246
Texas Oncology Midtown Dallas Texas 75251
University of Texas Southwestern Medical Center University of TX SW Med Ctr(2) Dallas Texas 75390-8852
University of Texas/MD Anderson Cancer Center SC-5 Houston Texas 77030-4009
Baylor College of Medicine Baylor Houston Texas 77030
Longview Cancer Center Longview Cancer Center (2) Longview Texas 75601
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) San Antonio Texas 78229
South Texas Oncology and Hematology, PA South Texas Oncology (2) San Antonio Texas 78258
Tyler Cancer Center Dept.ofTylerCancerCtr. (2) Tyler Texas 75702
Utah Cancer Specialists Utah Cancer (2) Salt Lake City Utah 84106
Virginia Cancer Specialists Fairfax No.VA (2) Fairfax Virginia 22031
Virginia Oncology Associates Dept. of VOA (2) Norfolk Virginia 23502
Swedish Cancer Institute Swedish Cancer Institute Seattle Washington 98104
Green Bay Oncology Green Bay Oncology Green Bay Wisconsin 54301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 118 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01007942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2017 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01007942 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →